The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Risk factors for damage in childhood‐onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage
Abstract
Objective: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index measures damage in adult patients with systemic lupus erythematosus (SLE), but its usefulness in patients with childhood‐onset SLE has not been examined. This study was conducted to evaluate the sensibility of the SLICC/ACR Damage Index, to investigate how cumulative disease activity is related to damage in childhood‐onset SLE, and to identify other risk factors for damage in childhood‐onset SLE. Methods: Disease activity and damage in 66 patients with newly diagnosed childhood‐onset SLE were assessed retrospectively, and information on potential risk factors for damage (age, race, sex, medications, duration of disease, hypertension, body mass index, antiphospholipid antibodies, kidney disease, acute thrombocytopenia) was obtained. In addition, a group of physicians was surveyed to establish the sensibility of the SLICC/ACR Damage Index in childhood‐onset SLE. Results: The SLICC/ACR Damage Index was found to have face, content, and construct validity when used in children. The mean SLICC/ACR Damage Index score of the patients was 1.76 (mean followup 3.3 years). Cumulative disease activity over time was the single best predictor of damage (R 2 = 0.30). Other, possibly important risk factors for damage were corticosteroid treatment, the presence of antiphospholipid antibodies, and acute thrombocytopenia. It was determined that immunosuppressive agents may be protective. Conclusion: The SLICC/ACR Damage Index, though useful in childhood‐onset SLE, may benefit from the introduction of weightings and redefinition of some of the items. Ongoing disease activity leads to disease damage, and treatment should be prompt. Prolonged use of high‐dose corticosteroids may further increase damage, but use of immunosuppressive agents may protect against disease damage; this latter finding may have potential implications for the treatment of childhood‐onset SLE and deserves further study. The relationship between disease activity and concomitant use of medication also requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Self-citationGladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Sanchez‐Guerrero, J., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,582
Liang, M. H., Socher, S. A., Larson, M. G., & Schur, P. H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320909 · Cited by 789
Gladman, D. D., Urowitz, M. B., Goldsmith, C. H., Fortin, P., Ginzler, E., Gordon, C., Hanly, J. G., Isenberg, D. A., Kalunian, K., Nived, O., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400506 · Cited by 759
(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068841 · Cited by 567
Damage in systemic lupus erythematosus and its association with corticosteroids
Zonana-Nacach, A., Barr, S. G., Magder, L. S., & Petri, M. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1801::aid-anr16>3.0.co;2-o · Cited by 495
The epidemiology of systemic lupus erythematosus
Siegel, M., & Lee, S. L. (1973) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(73)90034-6 · Cited by 407
TUCKER, L. B., MENON, S., SCHALLER, J. G., & ISENBERG, D. A. (1995) · Rheumatology · doi:10.1093/rheumatology/34.9.866 · Cited by 398
Prognosis in systemic lupus erythematosus
Reveille, J. D., Bartolucci, A., & Alarcón, G. S. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330105 · Cited by 330
Font, J., Cervera, R., Espinosa, G., Pallarés, L., Ramos-Casals, M., Jiménez, S., García-Carrasco, M., Seisdedos, L., & Ingelmo, M. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.8.456 · Cited by 301
Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90151-m · Cited by 278
Abu‐Shakra, M., Urowitz, M. B., Gladman, D. D., & Gough, J. (1995) · PubMed · Cited by 248
Brunner, H. I., Feldman, B. M., Bombardier, C., & Silverman, E. D. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199907)42:7<1354::aid-anr8>3.0.co;2-4 · Cited by 228
Self-citationKarlson, E. W., Daltroy, L. H., Lew, R. A., Wright, E. A., Partridge, A. J., Fossel, A. H., Roberts, W. N., Stern, S. H., Straaton, K. V., Wacholtz, M. C., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400108 · Cited by 223
Families of lines: random effects in linear regression analysis
Feldman, H. A. (1988) · Journal of Applied Physiology · doi:10.1152/jappl.1988.64.4.1721 · Cited by 223
Indexes and boundaries for “quantitative significance” in statistical decisions
Burnand, B., Kernan, W. N., & Feinstein, A. R. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90093-5 · Cited by 209
Ward, M. M. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390160099020 · Cited by 190
Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand, V., Gladman, D. D., Isenberg, D. A., Petri, M., Smolen, J. S., & Tugwell, P. (1999) · PubMed · Cited by 179
Choosing among generalized linear models applied to medical data
Lindsey, J. K., & Jones, B. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980115)17:1<59::aid-sim733>3.0.co;2-7 · Cited by 178
Bencivelli, W., Vitali, C., Isenberg, D. A., Smolen, J. S., Snaith, M. L., Sciuto, M. E., & Bombardieri, S. (1992) · PubMed · Cited by 154
Clinical, serologic, and immunogenetic studies in childhood‐onset systemic lupus erythematosus
Barron, K. S., Silverman, E. D., Gonzales, J. C., & Reveille, J. D. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360310 · Cited by 130
Self-citationPetri, M. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70135-6 · Cited by 121
Hook, E. B., & Regal, R. R. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009077 · Cited by 94
Estimating prognosis in systemic lupus erythematosus
Fries, J. F., Weyl, S., & Holman, H. R. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90007-2 · Cited by 91
The Prognosis of Lupus Nephritis in African-Americans: A Retrospective Analysis
Bakir, A. A., Levy, P. S., & Dunea, G. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80177-6 · Cited by 89
Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis
Press, J., Palayew, K., Laxer, R. M., Elkon, K. B., Eddy, A. A., Rakoff, D., & Silverman, E. D. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390420 · Cited by 83
Self-citationStoll, T. M., Stucki, G., Malik, J., Pyke, S. D. M., & Isenberg, D. A. (1997) · PubMed · Cited by 78
The significance of thrombocytopenia in systemic lupus erythematosus
Miller, M. H., Urowitz, M. B., & Gladman, D. D. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780261002 · Cited by 59
Swaak, A. J. G., Nossent, J. C., BRONSVELD, W., van Rooyen, A., Nieuwenhuys, E. J., Theuns, L., & Smeenk, R. J. T. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.6.455 · Cited by 59
Marini, R., & Costallat, L. T. L. (1999) · PubMed · Cited by 47
Trends in recent systemic lupus erythematosus mortality rates
Gordon, M. F., Stolley, P. D., & Schinnar, R. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780240602 · Cited by 42
Assessment of lupus: where are we now?
Hay, E. M., Gordon, C., & Emery, P. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.169 · Cited by 25
Cited by
Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus
Brunner, H. I., Gladman, D. D., Ibañez, D., Urowitz, M. D., & Silverman, E. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23204 · Cited by 554
Self-citationde Ferranti, S. D., Steinberger, J., Ameduri, R., Baker, A., Gooding, H., Kelly, A. S., Mietus-Snyder, M., Mitsnefes, M. M., Peterson, A. L., St-Pierre, J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000618 · Cited by 441
Tucker, L., Uribe, A., Fernández, M., Vilá, L., McGwin, G., Apte, M., Fessler, B., Bastian, H., Reveille, J., & Alarcón, G. (2008) · Lupus · doi:10.1177/0961203307087875 · Cited by 377
Prevalence and burden of pediatric-onset systemic lupus erythematosus
Kamphuis, S., & Silverman, E. D. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.121 · Cited by 360
Self-citationSystemic Lupus Erythematosus in Children and Adolescents
Levy, D. M., & Kamphuis, S. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.03.007 · Cited by 359
Metadata
- Authors
- Brunner, H. I., Silverman, E. D., To, T., Bombardier, C., & Feldman, B. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-02
- Volume
- 46
- Issue
- 2
- Pages
- 436-444
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2039883294
- Cited by
- 319
- References
- 35
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.